- Pregnancy in myelodysplastic syndrome2003 | Faculty of Physical Education and Sport
- Myelodysplastic syndrome +12013 | First Faculty of Medicine
- New findings on the pathogenesis of myelodysplastic syndrome2012 | First Faculty of Medicine
- Current options for biological treatment in patients with myelodysplastic syndrom2022 | First Faculty of Medicine
- Myelodysplastic syndrome2011 | Publication without faculty affiliation
- Auto- and Alloreactivity of T Lymphocytes in Myelodysplastic Syndrome2006 | Faculty of Physical Education and Sport
- Secondary myelodysplastic syndrome2018 | Faculty of Medicine in Hradec Králové
- Myelodysplastic syndromes – therapy progress over the last two decades2013 | First Faculty of Medicine
- Experiences with chelation therapy in myelodysplastic syndrome.2009 | Publication without faculty affiliation
- The principles of myelodysplastic syndrome treatment2010 | Faculty of Medicine in Hradec Králové
- Promising treatment modalities in the therapy of myelodysplastic syndromes2021 | First Faculty of Medicine
- Novel aproaches in therapy of low-risk patients with myelodysplastic syndrome2009 | Publication without faculty affiliation
- New therapeutic approaches and perspectives in the treatment of myelodysplastic syndrome2019 | First Faculty of Medicine
- Therapy-related myelodysplastic syndrome: a retrospective analysis of data from the Czech Working MDS Group registry2009 | Faculty of Medicine in Hradec Králové
- Therapy-related myelodysplastic syndrome: a retrospective analysis of data from the Czech Working MDS Group registry2009 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Therapy-related myelodysplastic syndrome: a retrospective analysis of data from the Czech Working MDS Group registry2009 | First Faculty of Medicine
- Treatment strategies for myelodysplastic syndrome in 20212021 | Faculty of Medicine in Hradec Králové
- Auto- and Alloreactivity of T Lymphocytes in Myelodysplastic Syndrome2006 | Second Faculty of Medicine
- Molecular cytogenetic study of 69 patients with myelodysplastic syndromes and complex chromosomal aberrationsPublication without faculty affiliation
- Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients2021 | First Faculty of Medicine
- Principles of treatment of patients with early forms of myelodysplastic syndrome2013 | First Faculty of Medicine
- The benefit of luspatercept in the treatment of low‑risk myelodysplastic syndrome – case report2023 | First Faculty of Medicine
- DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population2013 | First Faculty of Medicine
- Immune deregulation in myelodysplastic syndromes - the role of cytokines and soluble adhesion molecules. A pilot study2023 | Faculty of Medicine in Hradec Králové
- Therapy-related myelodysplastic syndrome : a retrospective analysis of data from the Czech Working MDS Group registry2009 | First Faculty of Medicine
- Treatment of anaemia with erythropoiesis-stimulating proteins in patients with myelodysplastic syndrome2010 | First Faculty of Medicine
- Treatment of anaemia with erythropoiesis-stimulating proteins in patients with myelodysplastic syndrome2010 | Publication without faculty affiliation
- Frequent Chromatin Rearrangements in Myelodysplastic Syndromes - What Stands Behind?2014 | First Faculty of Medicine
- Pregnancy in myelodysplastic syndrome2003 | First Faculty of Medicine